NP/PA Connect
News
Media
Conferences
Events
Publication
CME/CE
Resources
Editorial Advisory Board
Partners
Subscribe

Chronic Spontaneous Urticaria

Quality of Life in CSU Shaped by More Than Skin Symptoms

Quality of Life in CSU Shaped by More Than Skin Symptoms

1 day ago

The review emphasizes that psychological stress can influence inflammatory pathways involved in CSU, potentially worsening disease activity.

Latest News

First Biologic for Pediatric CSU Approved: Here's What It Means for Your Patients

First Biologic for Pediatric CSU Approved: Here's What It Means for Your Patients about 1 month ago

In the Chair: Hereditary Angioedema and CSU

In the Chair: Hereditary Angioedema and CSU about 2 months ago

FDA Approves Dupilumab for Chronic Spontaneous Urticaria in Children Aged 2 to 11

FDA Approves Dupilumab for Chronic Spontaneous Urticaria in Children Aged 2 to 11 about 2 months ago

Treatment Considerations for Type 2 Inflammation

Treatment Considerations for Type 2 Inflammation 3 months ago

Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging

Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging

Quality of Life in CSU Shaped by More Than Skin Symptoms

Quality of Life in CSU Shaped by More Than Skin Symptoms

KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show

KT-621 in Atopic Dermatitis: What Early EASI and Pruritus Data Show

Monitoring Patients on Afamelanotide for EPP: Skin Exams, Labs, and Counseling

Monitoring Patients on Afamelanotide for EPP: Skin Exams, Labs, and Counseling

Postoperative Radiation Therapy for Keloids: Safety, Dosing, and Access

Postoperative Radiation Therapy for Keloids: Safety, Dosing, and Access

Amy Snow, MSPAS, PA-C, on Treating Acne Beyond Topicals: Diet, Myths, and Influencer Trends

Amy Snow, MSPAS, PA-C, on Treating Acne Beyond Topicals: Diet, Myths, and Influencer Trends

Shawna Jones, PA-C, on Trust & Trends in Preventative Aesthetics

Shawna Jones, PA-C, on Trust & Trends in Preventative Aesthetics

Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis

Oral STAT6 Degrader KT-621 Shows Biologic-Comparable Activity in Atopic Dermatitis

How Project Happy Face is Revolutionizing Acne Care for Underserved Teens

How Project Happy Face is Revolutionizing Acne Care for Underserved Teens

Christopher Bunick, MD, PhD, on Bemotrizinol Approval and Its Role in US Sun Protection

Christopher Bunick, MD, PhD, on Bemotrizinol Approval and Its Role in US Sun Protection

Podcasts

Quality of Life in CSU Shaped by More Than Skin Symptoms

Quality of Life in CSU Shaped by More Than Skin Symptoms

Don't Be Rash: The Sturge-Weber Foundation's 40-Year Case for Early, Coordinated Care

Don't Be Rash: The Sturge-Weber Foundation's 40-Year Case for Early, Coordinated Care

Don't Be Rash: Rethinking Skin Disease in Down Syndrome

Don't Be Rash: Rethinking Skin Disease in Down Syndrome

The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment

The Cutaneous Connection: Debunking Allergy Myths and the Future of Atopic Dermatitis Treatment

The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis

The Cutaneous Connection: Diving Into the Safety and Efficacy of Icotrokinra, the New Oral IL-23 Peptide in Psoriasis

First Biologic for Pediatric CSU Approved: Here's What It Means for Your Patients

First Biologic for Pediatric CSU Approved: Here's What It Means for Your Patients

In the Chair: Hereditary Angioedema and CSU

In the Chair: Hereditary Angioedema and CSU

FDA Approves Dupilumab for Chronic Spontaneous Urticaria in Children Aged 2 to 11

FDA Approves Dupilumab for Chronic Spontaneous Urticaria in Children Aged 2 to 11

Don’t Be Rash: Introducing Andrew C. Krakowski, MD, and the Pediatric Dermatology Journey

Don’t Be Rash: Introducing Andrew C. Krakowski, MD, and the Pediatric Dermatology Journey

The Cutaneous Connection: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?

The Cutaneous Connection: Can GLP-1 Therapy Revolutionize Chronic Skin Treatment?

Continuing Medical Education

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

In-Person Event

Revolutionizing Atopic Dermatitis (RAD) Conference 2026

June 17-19, 2026

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Clinical Consultations™: Providing Holistic Care for Complex Cases of Psoriasis with Cardiovascular Comorbidities

Brittany Weber MD, PhD, FACC, FAHA; Lourdes M. Perez-Chada MD, MMSc

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Understanding Topical Steroid Withdrawal (TSW) in Patients With Atopic Dermatitis (AD)

Diego Ruiz Dasilva, MD, FAAD; Brad Glick, DO, MPH. FAAD; Peter Lio, MD

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Navigating Safety Data with Janus Kinase (JAK) Inhibitors in Atopic Dermatitis (AD) Management

Andrew Alexis, MD, MPH; Leon Kircik, MD

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Assessing the Evidence for OX40-OX40L Axis Inhibition for the Treatment of Atopic Dermatitis

Johann Gudjonsson, MD, PhD; Christopher Bunick, MD, PhD

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Cases and Conversations™: Biologic Matchmaking in Psoriasis – Finding the Right Therapy for the Right Patient

Douglas DiRuggiero, DMSc, MHS, PA-C; Lakshi Aldredge, MSN, ANP-BC, DCNP, FAANP

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Burst CME™: Optimizing Care for Patients with Psoriasis – Incorporating a Buy-and-Bill Model for Biologic Agents into Dermatological Practice

Jerry Bagel, MD, MS

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Patient, Provider, and Caregiver Connection™: Addressing Patient Challenges With Holistic Approaches to Vitiligo Management

Andrew F. Alexis, MD, MPH; Chesahna Kindred, MD, MBA, FAAD

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hidradenitis Suppurativa: Diving Deeper Into Disease Pathogenesis, Severity Assessment, and Holistic Management Approaches

Hadar Lev-Tov, MD; Martina Porter, MD

All News

WhatsApp Pilot Highlights Persistent Care Gaps in CSU

ByMaddi Hebebrand, MC, Associate Editor

January 19th 2026

A WhatsApp-based pilot study revealed high patient knowledge and significant challenges in managing CSU among Spanish speakers.

Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials

ByMarie Bosslett, Assistant Editor

January 13th 2026

Recludix Pharma has initiated clinical trials for REX-8756, a promising oral STAT6 inhibitor targeting inflammatory diseases, marking a significant milestone in treatment innovation.

Trending on Dermatology Times

Digital Twins in Dermatology: Your Patient’s Virtual Double Is Coming

FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years

Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show

Quality of Life in CSU Shaped by More Than Skin Symptoms

Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging